Benjamin F. Edwards & Company’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$3.52M Buy
143,548
+8,706
+6% +$213K 0.06% 280
2024
Q1
$3.35M Buy
134,842
+6,597
+5% +$163K 0.06% 270
2023
Q4
$3.24M Buy
128,245
+115,817
+932% +$2.76M 0.06% 254
2023
Q3
$292K Buy
12,428
+2,291
+23% +$55.3K 0.01% 640
2023
Q2
$250K Buy
10,137
+591
+6% +$14.6K 0.01% 673
2023
Q1
$239K Buy
9,546
+6,814
+249% +$169K 0.01% 665
2022
Q4
$66K Sell
2,732
-2,113
-44% -$50.7K ﹤0.01% 1009
2022
Q3
$114K Buy
+4,845
New +$123K 0.01% 821

Other funds holding IBDX

Benjamin F. Edwards & Company's IBDX Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 6.5% in Q2 2024, buying an estimated $213K and bringing the position to 143,548 shares worth $3.52M. The position accounts for 0.06% of the portfolio, ranked #280.

Benjamin F. Edwards & Company first reported a position in IBDX in Q3 2022 and has held it in 8 quarters since. 106 funds tracked by Wall St. Rank hold IBDX as of Q2 2024.

  • Benjamin F. Edwards & Company held 143,548 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $3.52M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 8,706 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2024, an estimated $213K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.06% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #280 holding.
  • Benjamin F. Edwards & Company first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2022 and has held it in 8 quarters since.
  • 106 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.